CD4 and atherosclerosis: This persistent immune activation may have important clinical consequences; for example, persistent T cell activation is associated with lower CD4 cell count increases in patients receiving ART [17],[18],[19] and may contribute to accelerated atherosclerosis [20] or premature immunosenescence.